Search Results 941-950 of 17390 for soluble fibers

1. Down Regulation on the Autonomic Nervous System Following Physical & Cognitive Stress - Mayo Clinic

   The purpose of this repeated measures study is to test the effectiveness of down regulation techniques to mitigate the psycho-physiologic response to stress ...

2. Cardiovascular Medicine - Clinical trials

   The purpose of this study is to determine the accuracy (sensitivity, specificity, negative predictive value, positive predictive value) of a new venous air ...

3. Investigating African American-specific AD-related ABCA7 Variants Using Isogenic hiPSCs - Mayo Clinic

   About this study. In this proposal, we will generate hiPSCs from AA patients and use our TREE-based approaches to introduce AA-associated variants into ...

4. A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of Persistent Post-Traumatic Headache (PPTH) - Mayo Clinic

   A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of Persistent Post-Traumatic Headache (PPTH).

5. A Clinical Study Of KTX-2001 In Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

   Study K36-MCRPC-001 is the first in human clinical trial testing KTX-2001 alone and with darolutamide in men with metastatic castration-resistant prostate ...

6. A Global Study to Assess the Effects of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer - Mayo Clinic

   Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements are ...

7. ABT-888 With Cyclophosphamide in Refractory BRCA-Positive Ovarian, Primary Peritoneal or Ovarian High-Grade Serous Carcinoma, Fallopian Tube Cancer, Triple-Negative Breast Cancer, and Low-Grade Non-Hodgkin's Lymphoma - Mayo Clinic

   ABT-888 With Cyclophosphamide in Refractory BRCA-Positive Ovarian, Primary Peritoneal or Ovarian High-Grade Serous Carcinoma, Fallopian Tube Cancer, Triple- ...

8. Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis - Mayo Clinic

   This phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment.

9. Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer - Mayo Clinic

   Trastuzumab emtansine may kill cancer cells by binding to HER2-positive on the surface of the tumor cells and blocking their ability grow and spread.

10. All of Us Research Program Biobank - Mayo Clinic

    All of Us is a service mark of the Department of Health and Human Services. Share · Tweet . VID-20456961. Home; All of Us Research Program Biobank ...